213 is the total number of securities INTERNATIONAL BIOTECHNOLOGY TRUST PLC has owned. The longest INTERNATIONAL BIOTECHNOLOGY TRUST PLC has owned a single stock is 28 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| GILD | GILEAD SCIENCES INC COMMO | 28 | 28 | 0.24% | 4.85% | 9.26% | Q4 2016 | Q3 2023 | 28 |
| INCY | INCYTE CORP INC COM | 28 | 28 | 0.58% | 3.86% | 7.88% | Q4 2016 | Q3 2023 | 28 |
| BMRN | BIOMARIN PHARMACEUTICA... | 28 | 28 | 0.05% | 2.86% | 7.54% | Q4 2016 | Q3 2023 | 28 |
| REGN | REGENERON PHARMS. | 14 | 13 | 0.25% | 3.92% | 8.98% | Q4 2016 | Q3 2023 | 27 |
| BIIB | BIOGEN INC COMMON STOCK | 13 | 6 | 0.54% | 4.03% | 8.71% | Q4 2016 | Q3 2023 | 26 |
| VRTX | VERTEX PHARMS. | 22 | 3 | 0.73% | 4.79% | 8.44% | Q4 2016 | Q3 2023 | 25 |
| AMGN | AMGEN INC COM | 20 | 5 | 0.42% | 4.27% | 7.92% | Q4 2016 | Q3 2023 | 25 |
| NBIX | NEUROCRINE BIOSCIENCES... | 21 | 2 | 0.63% | 3.47% | 6.88% | Q4 2016 | Q3 2023 | 25 |
| ALNY | ALYNYLAM PHARMACEUTICA... | 25 | 25 | 0.40% | 2.38% | 6.66% | Q3 2017 | Q3 2023 | 25 |
| IONS | IONIS PHARMS. | 22 | 3 | 0.36% | 1.24% | 3.97% | Q1 2017 | Q3 2023 | 25 |
| EXEL | EXELIXIS INC COM | 20 | 4 | 0.49% | 2.79% | 5.65% | Q4 2016 | Q1 2023 | 24 |
| KALV | KALVISTA PHARMS. | 24 | 24 | 0.72% | 1.51% | 4.00% | Q4 2016 | Q3 2022 | 24 |
| AGIO | AGIOS PHARMS. | 22 | 2 | 0.16% | 0.50% | 1.18% | Q1 2017 | Q3 2023 | 24 |
| HALO | HALOZYME THERAPEUTICS INC | 19 | 3 | 0.26% | 1.88% | 3.59% | Q4 2016 | Q3 2023 | 22 |
| SUPN | SUPERNUS PHARMS. | 12 | 10 | 0.17% | 1.81% | 4.79% | Q1 2017 | Q3 2023 | 22 |
| FOLD | AMICUS THERAPEUTICS INC C | 20 | 1 | 0.12% | 0.34% | 0.99% | Q4 2016 | Q3 2023 | 22 |
| ACAD | ACADIA PHARMACEUTICALS... | 11 | 4 | 0.38% | 2.46% | 7.10% | Q4 2016 | Q3 2023 | 21 |
| ILMN | ILLUMINA INC COM | 9 | 1 | 0.50% | 2.96% | 6.90% | Q4 2016 | Q3 2023 | 20 |
| SRPT | SAREPTA THERAPEUTICS INC | 17 | 1 | 0.26% | 1.08% | 2.14% | Q4 2016 | Q3 2023 | 20 |
| PTCT | PTC Therapuetics COM | 19 | 19 | 0.13% | 2.95% | 5.55% | Q1 2019 | Q3 2023 | 19 |
| MRTX | MIRATI THERAPEUTICS INC C | 19 | 19 | 0.31% | 2.14% | 4.20% | Q1 2019 | Q3 2023 | 19 |
| INSM | INSMED INC COM PAR $.01 | 19 | 19 | 0.19% | 0.91% | 3.38% | Q1 2019 | Q3 2023 | 19 |
| HZNP | HORIZON THERAPEUTICS P... | 10 | 1 | 0.34% | 2.62% | 11.06% | Q4 2016 | Q2 2023 | 18 |
| QURE | UNIQURE N.V. COM EUR0.05 | 18 | 18 | 0.05% | 1.72% | 4.66% | Q2 2019 | Q3 2023 | 18 |
| ALXN | ALEXION PHARMACEUTICAL... | 17 | 17 | 2.78% | 4.12% | 7.38% | Q4 2016 | Q4 2020 | 17 |
| SAGE | SAGE THERAPEUTICS INC | 15 | 1 | 0.29% | 1.26% | 4.43% | Q4 2016 | Q2 2023 | 17 |
| ASND | ASCENDIS PHARMA A/S SPONS | 17 | 17 | 0.31% | 0.73% | 1.13% | Q1 2019 | Q1 2023 | 17 |
| BLUE | BLUEBIRD BIO INC | 17 | 17 | 0.05% | 0.63% | 1.33% | Q3 2017 | Q3 2021 | 17 |
| FGEN | FIBROGEN INC | 17 | 17 | 0.05% | 0.38% | 0.75% | Q3 2017 | Q3 2021 | 17 |
| JAZZ | JAZZ PHARMS. | 10 | 3 | 0.18% | 1.02% | 1.60% | Q4 2016 | Q3 2023 | 16 |
| NKTR | NEKTAR THERAPEUTICS | 13 | 1 | 0.20% | 0.77% | 4.44% | Q4 2016 | Q4 2021 | 16 |
| GWPH | GW PHARMACEUTICALS PLC | 13 | 3 | 0.32% | 0.52% | 1.05% | Q4 2016 | Q4 2020 | 16 |
| ITCI | INTRA CELLULAR THERAPI... | 15 | 15 | 0.16% | 2.00% | 5.57% | Q1 2020 | Q3 2023 | 15 |
| SGEN | SEATTLE GENETICS INC | 15 | 15 | 0.87% | 1.87% | 4.14% | Q1 2017 | Q3 2020 | 15 |
| GBT | GLOBAL BLOOD THERAPEUT... | 13 | 2 | 0.13% | 0.39% | 0.82% | Q1 2017 | Q1 2022 | 15 |
| ANAB | ANAPTYSBIO INC COM | 12 | 1 | 0.05% | 0.20% | 1.07% | Q1 2017 | Q2 2022 | 15 |
| XLRN | ACCELERON PHARMA INC | 10 | 4 | 0.21% | 1.38% | 2.58% | Q4 2016 | Q2 2021 | 14 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 13 | 1 | 0.10% | 0.67% | 2.85% | Q2 2019 | Q3 2023 | 14 |
| STRO | SUTRO BIOPHARMA INC | 14 | 14 | 0.36% | 0.62% | 0.84% | Q3 2018 | Q4 2021 | 14 |
| DCPH | DECIPHERA PHARMACEUTIC... | 9 | 5 | 0.14% | 0.59% | 1.19% | Q3 2017 | Q3 2021 | 14 |
| BPMC | BLUEPRINT MEDICINES CORP | 13 | 1 | 0.20% | 0.44% | 0.60% | Q2 2019 | Q3 2023 | 14 |
| AUPH | Aurinia Pharmaceutical... | 13 | 13 | 0.30% | 1.57% | 5.98% | Q3 2020 | Q3 2023 | 13 |
| RDUS | RADIUS HEALTH INC | 13 | 13 | 0.12% | 0.54% | 2.12% | Q4 2016 | Q4 2019 | 13 |
| CELG | CELGENE CORP | 12 | 12 | 4.88% | 7.75% | 10.24% | Q4 2016 | Q3 2019 | 12 |
| STML | STEMLINE THERAPEUTICS INC | 12 | 12 | 0.79% | 2.84% | 4.23% | Q1 2017 | Q4 2019 | 12 |
| RARE | Ultragenyx Pharmaceuti... | 11 | 1 | 0.47% | 1.82% | 3.00% | Q1 2018 | Q3 2023 | 12 |
| BGNE | BEIGENE LTD SPONSORED ADR | 8 | 1 | 0.16% | 0.92% | 2.57% | Q1 2017 | Q3 2023 | 12 |
| CRSP | CRISPR THERAPEUTICS AG CO | 6 | 1 | 0.36% | 0.70% | 1.82% | Q4 2019 | Q3 2023 | 12 |
| LGND | LIGAND PHARMACEUTICALS... | 11 | 11 | 0.31% | 1.68% | 3.72% | Q4 2016 | Q2 2019 | 11 |
| TVTX | TRAVERE THERAPEUTICS INC | 11 | 11 | 0.08% | 1.49% | 3.96% | Q4 2020 | Q2 2023 | 11 |
| DYN | DYNE THERAPEUTICS INC COM | 11 | 11 | 0.26% | 1.46% | 5.87% | Q1 2021 | Q3 2023 | 11 |
| IMAB | I-MAB SPONSORED ADS | 11 | 11 | 0.13% | 0.83% | 5.77% | Q1 2021 | Q3 2023 | 11 |
| ARNA | Arena Pharmaceuticals Inc | 7 | 4 | 0.27% | 0.35% | 0.44% | Q1 2019 | Q4 2021 | 11 |
| EXAS | Exact Sciences Corp | 11 | 11 | 0.19% | 0.34% | 0.47% | Q2 2019 | Q4 2021 | 11 |
| SGEN | SEAGEN INC COM | 10 | 10 | 0.05% | 4.84% | 11.30% | Q4 2020 | Q1 2023 | 10 |
| HRMY | Harmony Biosciences Holdi | 10 | 10 | 1.24% | 3.56% | 6.11% | Q2 2021 | Q3 2023 | 10 |
| BHVN | BIOHAVEN PHARM. HLDG. | 8 | 2 | 0.57% | 3.00% | 5.91% | Q1 2019 | Q1 2022 | 10 |
| ARRY | ARRAY BIOPHARMA INC | 10 | 10 | 0.26% | 2.06% | 5.42% | Q4 2016 | Q1 2019 | 10 |
| CCXI | CRISPR THERAPEUTICS AG | 10 | 10 | 0.29% | 2.02% | 4.31% | Q1 2020 | Q2 2022 | 10 |
| TPTX | TURNING POINT THERAPEU... | 10 | 10 | 0.66% | 1.64% | 3.77% | Q4 2019 | Q1 2022 | 10 |
| ZGNX | ZOGENIX INC | 8 | 2 | 0.26% | 1.31% | 3.17% | Q3 2018 | Q4 2021 | 10 |
| AERI | AERIE PHARMACEUTICALS INC | 10 | 10 | 0.26% | 1.15% | 2.81% | Q4 2016 | Q1 2019 | 10 |
| ZLAB | Zai Lab Ltd ADR (V1 Ord) | 10 | 10 | 0.54% | 1.04% | 3.82% | Q2 2021 | Q3 2023 | 10 |
| SGMO | SANGAMO THERAPEUTICS INC | 10 | 10 | 0.17% | 0.78% | 1.59% | Q3 2017 | Q4 2019 | 10 |
| GH | GUARDANT HEALTH INC COM | 10 | 10 | 0.06% | 0.73% | 1.66% | Q2 2021 | Q3 2023 | 10 |
| XENE | Xenon Pharmaceuticals ... | 10 | 10 | 0.09% | 0.36% | 1.05% | Q2 2021 | Q3 2023 | 10 |
| UTHR | UTD. THERAPEUTICS | 7 | 2 | 0.21% | 1.59% | 3.55% | Q1 2021 | Q3 2023 | 9 |
| RCKT | ROCKET PHARMS. | 9 | 9 | 0.30% | 0.94% | 4.03% | Q3 2021 | Q3 2023 | 9 |
| GTHX | G1 THERAPEUTICS INC | 5 | 4 | 0.11% | 0.80% | 1.66% | Q3 2017 | Q4 2019 | 9 |
| DERM | DERMIRA INC | 5 | 4 | 0.09% | 0.68% | 1.43% | Q4 2016 | Q4 2019 | 9 |
| HCM | Hutchmed China Ltd ADR... | 9 | 9 | 0.19% | 0.65% | 2.27% | Q2 2021 | Q2 2023 | 9 |
| LEGN | LEGEND BIOTECH CORP | 9 | 9 | 0.05% | 0.58% | 1.27% | Q3 2021 | Q3 2023 | 9 |
| AXSM | AXSOME THERAPEUTICS INC. | 4 | 2 | 0.11% | 0.57% | 1.37% | Q4 2020 | Q3 2023 | 9 |
| ESPR | ESPERION THERAPEUTICS ... | 8 | 1 | 0.03% | 0.17% | 0.64% | Q1 2018 | Q3 2021 | 9 |
| RLMD | RELMADA THERAPEUTICS INC | 9 | 9 | 0.01% | 0.06% | 0.17% | Q3 2021 | Q3 2023 | 9 |
| HZNP | HORIZON THERAPEUTICS P... | 8 | 8 | 1.14% | 6.31% | 9.76% | Q2 2019 | Q1 2021 | 8 |
| SHPG | SHIRE PLC | 5 | 3 | 1.62% | 3.35% | 7.31% | Q4 2016 | Q4 2018 | 8 |
| ADMS | ADAMAS PHARMACEUTICALS... | 8 | 8 | 1.23% | 2.58% | 3.76% | Q4 2016 | Q3 2018 | 8 |
| VERA | VERA THERAPEUTICS INC | 8 | 8 | 0.71% | 2.54% | 4.76% | Q4 2021 | Q3 2023 | 8 |
| ALKS | ALKERMES PLC SHS | 4 | 1 | 0.29% | 2.32% | 4.78% | Q1 2019 | Q1 2023 | 8 |
| KDNY | CHINOOK THERAPEUTICS INC | 8 | 8 | 0.64% | 1.75% | 3.55% | Q2 2021 | Q1 2023 | 8 |
| PRTA | PROTHENA CORP PLC USD0.01 | 3 | 1 | 0.16% | 1.10% | 5.38% | Q4 2016 | Q3 2023 | 8 |
| KRYS | KRYSTAL BIOTECH INC COM | 8 | 8 | 0.25% | 1.04% | 1.80% | Q4 2021 | Q3 2023 | 8 |
| DNLI | DENALI THERAPEUTICS INC C | 8 | 8 | 0.26% | 0.81% | 1.85% | Q4 2021 | Q3 2023 | 8 |
| APLS | APELLIS PHARMS. | 3 | 2 | 0.26% | 0.80% | 3.60% | Q1 2021 | Q2 2023 | 8 |
| MDGL | MADRIGAL PHARMS. | 3 | 1 | 0.06% | 0.77% | 1.29% | Q4 2017 | Q3 2023 | 8 |
| GMED | Globus Med Inc | 8 | 8 | 0.38% | 0.52% | 0.60% | Q1 2018 | Q4 2019 | 8 |
| IRWD | IRONWOOD PHARMACEUTICA... | 4 | 4 | 0.18% | 0.35% | 0.63% | Q4 2016 | Q1 2023 | 8 |
| NTLA | INTELLIA THERAPEUTICS INC | 8 | 8 | 0.12% | 0.31% | 0.63% | Q4 2021 | Q3 2023 | 8 |
| MYOK | Myokardia INC | 7 | 7 | 0.34% | 1.14% | 2.90% | Q1 2019 | Q3 2020 | 7 |
| PTGX | PROTAGONIST THERAPEUTI... | 4 | 1 | 0.11% | 0.73% | 1.80% | Q3 2020 | Q3 2023 | 7 |
| TRXC | TRANSENTERIX INC | 7 | 7 | 0.24% | 0.62% | 1.47% | Q4 2016 | Q2 2018 | 7 |
| NVCR | NOVOCURE LTD | 6 | 1 | 0.33% | 0.61% | 1.08% | Q4 2019 | Q3 2023 | 7 |
| IDYA | IDEAYA BIOSCIENCES INC CO | 7 | 7 | 0.07% | 0.56% | 1.14% | Q3 2021 | Q1 2023 | 7 |
| PTLA | PORTOLA PHARMACEUTICAL... | 6 | 1 | 0.23% | 0.54% | 1.62% | Q1 2017 | Q4 2018 | 7 |
| ALLK | ALLAKOS INC | 7 | 7 | 0.32% | 0.42% | 0.60% | Q1 2020 | Q3 2021 | 7 |
| TSRO | TESARO INC | 6 | 6 | 0.48% | 2.23% | 5.72% | Q4 2016 | Q1 2018 | 6 |
| ABMD | Abiomed Inc | 6 | 6 | 0.96% | 1.57% | 2.16% | Q2 2018 | Q3 2019 | 6 |
| CLVS | CLOVIS ONCOLOGY INC | 6 | 6 | 0.49% | 1.40% | 1.82% | Q4 2016 | Q1 2018 | 6 |
| AMRN | Amarin Corp Plc | 6 | 6 | 0.53% | 1.33% | 3.00% | Q4 2018 | Q1 2020 | 6 |
| XENT | Intersect Ent Inc | 6 | 6 | 0.57% | 1.10% | 1.61% | Q1 2018 | Q2 2019 | 6 |
| ENTA | ENANTA PHARMACEUTICALS... | 2 | 2 | 0.40% | 1.07% | 2.15% | Q4 2018 | Q3 2021 | 6 |
| SGYPQ | SYNERGY PHARMACEUTICAL... | 6 | 6 | 0.56% | 1.01% | 1.30% | Q4 2016 | Q1 2018 | 6 |
| PRTK | PARATEK PHARMACEUTICAL... | 6 | 6 | 0.36% | 0.90% | 1.97% | Q2 2017 | Q3 2018 | 6 |
| FATE | FATE THERAPEUTICS INC COM | 6 | 6 | 0.14% | 0.78% | 1.65% | Q3 2021 | Q4 2022 | 6 |
| GMDA | Gamida Cell Ltd COM US... | 6 | 6 | 0.06% | 0.66% | 2.25% | Q1 2021 | Q2 2022 | 6 |
| MNTA | MOMENTA PHARMACEUTICAL... | 6 | 6 | 0.29% | 0.39% | 0.57% | Q1 2019 | Q2 2020 | 6 |
| ORIC | ORIC PHARMS. | 6 | 6 | 0.20% | 0.34% | 0.50% | Q4 2020 | Q1 2022 | 6 |
| ONCE | SPARK THERAPEUTICS INC | 6 | 6 | 0.22% | 0.30% | 0.42% | Q3 2017 | Q4 2018 | 6 |
| BEAM | BEAM THERAPEUTICS INC COM | 6 | 6 | 0.19% | 0.25% | 0.36% | Q2 2022 | Q3 2023 | 6 |
| ENTL | ENTELLUS MED INC | 5 | 5 | 1.80% | 2.56% | 3.44% | Q4 2016 | Q4 2017 | 5 |
| SNY | SANOFI | 5 | 5 | 0.33% | 1.62% | 2.18% | Q1 2022 | Q1 2023 | 5 |
| NVAX | NOVAVAX INC | 5 | 5 | 0.26% | 1.40% | 4.18% | Q1 2022 | Q1 2023 | 5 |
| RVNC | REVANCE THERAPEUTICS INC | 5 | 5 | 0.68% | 1.34% | 2.22% | Q3 2022 | Q3 2023 | 5 |
| BCRX | BIOCRYST PHARMS. | 5 | 5 | 0.13% | 1.10% | 4.35% | Q1 2022 | Q1 2023 | 5 |
| FULC | FULCRUM THERAPEUTICS INC | 5 | 5 | 0.19% | 0.68% | 2.02% | Q4 2021 | Q4 2022 | 5 |
| FOMX | FOAMIX PHARMACEUTICALS... | 3 | 2 | 0.13% | 0.59% | 0.99% | Q4 2016 | Q1 2018 | 5 |
| MLND | Millendo Therapeutics Inc | 5 | 5 | 0.34% | 0.51% | 0.76% | Q1 2019 | Q1 2020 | 5 |
| MIRM | MIRUM PHARMACEUTICALS INC | 5 | 5 | 0.06% | 0.43% | 0.72% | Q3 2022 | Q3 2023 | 5 |
| TCDA | Tricida Inc | 5 | 5 | 0.28% | 0.38% | 0.53% | Q1 2019 | Q1 2020 | 5 |
| SBPH | SPRING BR PHARMACEUTIC... | 5 | 5 | 0.32% | 0.36% | 0.43% | Q4 2017 | Q4 2018 | 5 |
| IMVT | IMMUNOVANT INC COM | 5 | 5 | 0.11% | 0.24% | 0.63% | Q2 2021 | Q2 2022 | 5 |
| XNCR | XENCOR INC | 5 | 5 | 0.14% | 0.24% | 0.57% | Q4 2016 | Q4 2017 | 5 |
| ALLO | ALLOGENE THERAPEUTICS INC | 5 | 5 | 0.10% | 0.23% | 0.52% | Q4 2021 | Q4 2022 | 5 |
| BLACK DIAMOND THERAPEUTIC | 5 | 5 | 0.02% | 0.20% | 0.47% | Q1 2022 | Q1 2023 | 5 | |
| ARVN | ARVINAS INC COM | 5 | 5 | 0.11% | 0.16% | 0.24% | Q3 2022 | Q3 2023 | 5 |
| ZEAL | ZEALAND PHARMA A S | 5 | 5 | 0.06% | 0.07% | 0.08% | Q4 2019 | Q4 2020 | 5 |
| CNCE | CONCERT PHARMACEUTICAL... | 3 | 1 | 0.31% | 1.89% | 6.47% | Q2 2019 | Q4 2022 | 4 |
| AKAOQ | ACHAOGEN INC | 4 | 4 | 0.46% | 1.30% | 2.70% | Q1 2017 | Q4 2017 | 4 |
| PBYI | PUMA BIOTECHNOLOGY INC | 4 | 4 | 0.42% | 1.20% | 2.41% | Q4 2017 | Q3 2018 | 4 |
| CARIBOU BIOSCIENCES INC C | 4 | 4 | 0.50% | 1.18% | 2.66% | Q2 2022 | Q1 2023 | 4 | |
| KRTX | KARUNA THERAPEUTICS INC C | 3 | 1 | 0.13% | 1.03% | 1.74% | Q2 2022 | Q3 2023 | 4 |
| ICPT | INTERCEPT PHARMACEUTIC... | 3 | 1 | 0.33% | 0.69% | 1.45% | Q4 2016 | Q2 2022 | 4 |
| CBAY | CYMABAY THERAPEUTICS INC | 4 | 4 | 0.47% | 0.63% | 0.75% | Q4 2017 | Q3 2018 | 4 |
| MRUS | MERUS NV | 3 | 1 | 0.37% | 0.52% | 0.65% | Q2 2017 | Q3 2018 | 4 |
| AKCA | AKCEA THERAPEUTICS INC | 4 | 4 | 0.19% | 0.37% | 0.78% | Q1 2019 | Q4 2019 | 4 |
| MYGN | Myriad Genetics inc | 4 | 4 | 0.24% | 0.36% | 0.47% | Q1 2019 | Q4 2019 | 4 |
| MGNX | MACROGENICS INC | 3 | 1 | 0.13% | 0.34% | 0.50% | Q4 2016 | Q1 2019 | 4 |
| SWTX | SPRINGWORKS THERAPEUTI... | 4 | 4 | 0.17% | 0.30% | 0.38% | Q3 2021 | Q2 2022 | 4 |
| NKTX | NKARTA INC | 4 | 4 | 0.05% | 0.29% | 0.58% | Q2 2021 | Q1 2022 | 4 |
| RSLS | RESHAPE LIFESCIENCES INC | 4 | 4 | 0.00% | 0.22% | 0.45% | Q4 2017 | Q3 2018 | 4 |
| IMMU | IMMUNOMEDICS INC | 3 | 3 | 0.44% | 2.30% | 5.10% | Q1 2020 | Q3 2020 | 3 |
| AZN | ASTRAZENECA PLC SPONSORED | 2 | 1 | 1.06% | 1.23% | 1.36% | Q4 2022 | Q3 2023 | 3 |
| ERASCA INC COM | 3 | 3 | 1.19% | 1.22% | 1.28% | Q1 2023 | Q3 2023 | 3 | |
| NEURODERM LTD | 3 | 3 | 0.65% | 1.22% | 1.90% | Q4 2016 | Q2 2017 | 3 | |
| KITE | KITE PHARMA INC | 3 | 3 | 0.74% | 1.09% | 1.66% | Q4 2016 | Q2 2017 | 3 |
| CALA | CALITHERA BIOSCIENCES INC | 3 | 3 | 0.41% | 0.98% | 1.38% | Q1 2017 | Q3 2017 | 3 |
| FPRX | FIVE PRIME THERAPEUTIC... | 3 | 3 | 0.47% | 0.91% | 1.38% | Q2 2017 | Q4 2017 | 3 |
| AVXS | AVEXIS INC | 3 | 3 | 0.64% | 0.71% | 0.82% | Q3 2017 | Q1 2018 | 3 |
| VNDA | VANDA PHARMACEUTICALS INC | 3 | 3 | 0.39% | 0.70% | 0.98% | Q4 2016 | Q2 2017 | 3 |
| GMAB | GENMAB -SP ADR | 1 | 1 | 0.53% | 0.68% | 0.93% | Q2 2022 | Q3 2023 | 3 |
| MTEM | MOLECULAR TEMPLATES INC | 3 | 3 | 0.13% | 0.59% | 0.87% | Q3 2017 | Q1 2018 | 3 |
| VCYT | VERACYTE INC | 3 | 3 | 0.54% | 0.57% | 0.60% | Q1 2017 | Q3 2017 | 3 |
| HARP | HARPOON THERAPEUTICS INC | 3 | 3 | 0.36% | 0.47% | 0.62% | Q3 2021 | Q1 2022 | 3 |
| ACET | ADICET BIO INC COM | 3 | 3 | 0.25% | 0.46% | 0.70% | Q3 2022 | Q1 2023 | 3 |
| TRILLIUM THERAPEUTICS INC | 3 | 3 | 0.26% | 0.45% | 0.56% | Q4 2016 | Q2 2017 | 3 | |
| OMER | OMEROS CORP | 3 | 3 | 0.23% | 0.32% | 0.51% | Q2 2017 | Q4 2017 | 3 |
| CYTK | CYTOKINETICS INC COMMON S | 2 | 1 | 0.18% | 0.30% | 0.37% | Q3 2020 | Q3 2023 | 3 |
| VKTX | VIKING THERAPEUTICS INC | 3 | 3 | 0.10% | 0.16% | 0.26% | Q4 2017 | Q2 2018 | 3 |
| VENTYX BIOSCIENCES INC CO | 3 | 3 | 0.14% | 0.16% | 0.18% | Q1 2023 | Q3 2023 | 3 | |
| BDTX | BLACK DIAMOND THERAPEU... | 3 | 3 | 0.05% | 0.09% | 0.14% | Q2 2021 | Q4 2021 | 3 |
| 2SEVENTY BIO INC-W/I | 3 | 3 | 0.02% | 0.03% | 0.04% | Q4 2021 | Q2 2022 | 3 | |
| MRK | MERCK & CO INC | 2 | 2 | 2.72% | 2.82% | 2.92% | Q4 2019 | Q1 2020 | 2 |
| SPPI | Spectrum Pharmaceutica... | 2 | 2 | 1.84% | 2.12% | 2.41% | Q2 2018 | Q3 2018 | 2 |
| GLPG | GALAPAGOS NV | 2 | 2 | 1.29% | 1.48% | 1.68% | Q2 2022 | Q3 2022 | 2 |
| AVDL | AVADEL PHARMS. | 2 | 2 | 0.52% | 1.12% | 1.72% | Q1 2022 | Q2 2022 | 2 |
| AMYLYX PHARMS. | 2 | 2 | 0.16% | 0.99% | 1.82% | Q2 2023 | Q3 2023 | 2 | |
| JUNO | JUNO THERAPEUTICS INC | 2 | 2 | 0.80% | 0.95% | 1.10% | Q3 2017 | Q4 2017 | 2 |
| RTRX | Retrophin Inc | 2 | 2 | 0.13% | 0.94% | 1.74% | Q1 2019 | Q2 2019 | 2 |
| VSTM | Verastem Inc | 2 | 2 | 0.46% | 0.89% | 1.32% | Q1 2018 | Q2 2018 | 2 |
| RGEN | REPLIGEN CORP | 2 | 2 | 0.76% | 0.81% | 0.85% | Q2 2019 | Q3 2019 | 2 |
| AKRO | AKERO THERAPEUTICS INC CO | 2 | 2 | 0.32% | 0.72% | 1.12% | Q2 2023 | Q3 2023 | 2 |
| IMUX | IMMUNIC INC | 2 | 2 | 0.51% | 0.62% | 0.74% | Q2 2020 | Q3 2020 | 2 |
| ARQL | Arqule INC | 2 | 2 | 0.14% | 0.56% | 0.98% | Q2 2019 | Q3 2019 | 2 |
| MARINUS PHARMACEUTICAL... | 2 | 2 | 0.30% | 0.54% | 0.79% | Q2 2023 | Q3 2023 | 2 | |
| PRNB | PRINCIPIA BIOPHARMA INC | 2 | 2 | 0.43% | 0.52% | 0.62% | Q1 2020 | Q2 2020 | 2 |
| MRSN | MERSANA THERAPEUTICS INC | 2 | 2 | 0.43% | 0.48% | 0.52% | Q3 2020 | Q4 2020 | 2 |
| CLDX | CELLDEX THERAPEUTICS I... | 2 | 2 | 0.44% | 0.47% | 0.50% | Q2 2023 | Q3 2023 | 2 |
| ALDR | ALDER BIOPHARMACEUTICA... | 2 | 2 | 0.19% | 0.47% | 0.75% | Q4 2016 | Q1 2017 | 2 |
| OPTN | OPTINOSE INC | 2 | 2 | 0.43% | 0.47% | 0.51% | Q4 2017 | Q1 2018 | 2 |
| RIGL | Rigel Pharmaceuticals Inc | 2 | 2 | 0.40% | 0.45% | 0.51% | Q1 2018 | Q2 2018 | 2 |
| IFRX | INFLARX NV | 1 | 1 | 0.31% | 0.38% | 0.45% | Q1 2019 | Q4 2019 | 2 |
| KOD | KODIAK SCIENCES INC | 2 | 2 | 0.31% | 0.34% | 0.38% | Q3 2021 | Q4 2021 | 2 |
| CRVS | Corvus Pharmaceuticals... | 2 | 2 | 0.34% | 0.34% | 0.34% | Q2 2018 | Q3 2018 | 2 |
| PCRX | PACIRA PHARMACEUTICALS... | 2 | 2 | 0.28% | 0.28% | 0.29% | Q1 2017 | Q2 2017 | 2 |
| ALBO | ALBIREO PHARMA INC COM | 2 | 2 | 0.10% | 0.18% | 0.25% | Q3 2022 | Q4 2022 | 2 |
| ARIA | ARIAD PHARMACEUTICALS INC | 1 | 1 | 3.69% | 3.69% | 3.69% | Q4 2016 | Q4 2016 | 1 |
| EXC | Exelixis Inc | 1 | 1 | 2.22% | 2.22% | 2.22% | Q4 2021 | Q4 2021 | 1 |
| WVE | WAVE LIFE SCIENCES LTD | 1 | 1 | 2.08% | 2.08% | 2.08% | Q1 2019 | Q1 2019 | 1 |
| MYL | MYLAN NV | 1 | 1 | 2.06% | 2.06% | 2.06% | Q2 2017 | Q2 2017 | 1 |
| BMY | BRISTOL MYERS SQUIBB CO | 1 | 1 | 2.04% | 2.04% | 2.04% | Q1 2017 | Q1 2017 | 1 |
| LLY | LILLY ELI & CO | 1 | 1 | 1.26% | 1.26% | 1.26% | Q1 2020 | Q1 2020 | 1 |
| UNITED THERAPEUTICS CO... | 1 | 1 | 1.07% | 1.07% | 1.07% | Q2 2017 | Q2 2017 | 1 | |
| VTRS | UNITED THERAPEUTICS CO... | 1 | 1 | 0.99% | 0.99% | 0.99% | Q3 2022 | Q3 2022 | 1 |
| AXGN | Axogen Inc | 1 | 1 | 0.71% | 0.71% | 0.71% | Q1 2018 | Q1 2018 | 1 |
| PEN | Penumbra Inc | 1 | 1 | 0.63% | 0.63% | 0.63% | Q1 2018 | Q1 2018 | 1 |
| CORT | CORCEPT THERAPEUTICS INC | 1 | 1 | 0.62% | 0.62% | 0.62% | Q3 2017 | Q3 2017 | 1 |
| CHRS | COHERUS BIOSCIENCES INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q1 2017 | Q1 2017 | 1 |
| MERUS NV | 1 | 1 | 0.50% | 0.50% | 0.50% | Q4 2017 | Q4 2017 | 1 | |
| COGT | COGENT BIOSCIENCES | 1 | 1 | 0.44% | 0.44% | 0.44% | Q3 2023 | Q3 2023 | 1 |
| Arena Pharmaceuticals Inc | 1 | 1 | 0.44% | 0.44% | 0.44% | Q4 2020 | Q4 2020 | 1 | |
| MERUS NV | 1 | 1 | 0.31% | 0.31% | 0.31% | Q1 2017 | Q1 2017 | 1 | |
| KZR | KEZAR LIFE SCIENCES | 1 | 1 | 0.28% | 0.28% | 0.28% | Q3 2023 | Q3 2023 | 1 |
| PIRS | PIERIS PHARMACEUTICALS... | 1 | 1 | 0.27% | 0.27% | 0.27% | Q2 2017 | Q2 2017 | 1 |
| BNTX | BIONTECH SE ADS | 1 | 1 | 0.27% | 0.27% | 0.27% | Q2 2022 | Q2 2022 | 1 |
| BBIO | BRIDGEBIO PHARMA INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2021 | Q4 2021 | 1 |
| PRQR | PROQR therapeutics N V | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2019 | Q2 2019 | 1 |
| ACOR | ACORDA THERAPEUTICS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2016 | Q4 2016 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTI... | 1 | 1 | 0.17% | 0.17% | 0.17% | Q4 2016 | Q4 2016 | 1 |
| ARDX | ARDELYX INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2021 | Q2 2021 | 1 |
| VIR | VIR BIOTECHNOLOGY INC COM | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2023 | Q3 2023 | 1 |
| MOR | MORPHOSYS AG | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2019 | Q4 2019 | 1 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2017 | Q3 2017 | 1 |
Download | |||||||||
The securities at the top of the list , including GILEAD SCIENCES INC COMMO, INCYTE CORP INC COM, and BIOMARIN PHARMACEUTICALS INC, are the highest-conviction holdings of INTERNATIONAL BIOTECHNOLOGY TRUST PLC.
The conviction is calculated by counting the number of quarters a security has been reported by INTERNATIONAL BIOTECHNOLOGY TRUST PLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that INTERNATIONAL BIOTECHNOLOGY TRUST PLC owns currently or has owned in the past.